---
title: 'The cardio-oncologic burden of breast cancer: molecular mechanisms and importance
  of preclinical models'
date: '2024-12-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39621070/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241202180341&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Breast cancer, the most prevalent cancer affecting women worldwide, poses
  a significant cardio-oncological burden. Despite advancements in novel therapeutic
  strategies, anthracyclines, HER2 antagonists, and radiation remain the cornerstones
  of oncological treatment. However, each carries a risk of cardiotoxicity, though
  the molecular mechanisms underlying these adverse effects differ. Common mechanisms
  include DNA damage response, increased reactive oxygen species, and mitochondrial
  ...
disable_comments: true
---
Breast cancer, the most prevalent cancer affecting women worldwide, poses a significant cardio-oncological burden. Despite advancements in novel therapeutic strategies, anthracyclines, HER2 antagonists, and radiation remain the cornerstones of oncological treatment. However, each carries a risk of cardiotoxicity, though the molecular mechanisms underlying these adverse effects differ. Common mechanisms include DNA damage response, increased reactive oxygen species, and mitochondrial ...